⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Robin Boliver-CampbellM.D.

Internal Medicine · Houston, TX 77074

NPI: 1003096033

Share:

8

🟢 Low

ML Fraud Detection Score: 88%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

1,998

Total Claims

$211K

Drug Cost

324

Beneficiaries

$653

Cost/Patient

Risk Score Breakdown 8/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-35%

Opioid rate vs peers

1.5% vs 2.2% avg

-54%

Cost per patient vs peers

$653 vs $1,411 avg

+20%

Brand preference vs peers

12.8% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

🤖

ML fraud detection score of 88% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.5%

Opioid Rate

29

Opioid Claims

$191

Opioid Cost

Long-Acting Rate

Brand vs Generic

87% generic

Brand: 251 claims · $175K

Generic: 1,717 claims · $35K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Dapagliflozin Propanediol19$17K
Ipratropium/Albuterol Sulfate24$12K
Empagliflozin15$12K
Fluticasone/Umeclidin/Vilanter11$8,356
Ipratropium Bromide12$5,593
Insulin Glargine,hum.Rec.Anlog11$5,088
Fluticasone Propion/Salmeterol13$3,489
Albuterol Sulfate74$2,219
Lidocaine17$1,978
Celecoxib17$1,774
Atorvastatin Calcium80$1,139
Clonidine12$1,125
Rosuvastatin Calcium16$892
Nifedipine15$848
Amlodipine Besylate111$744

Prescribing Profile

59

Unique Drugs

$29K

IRA Negotiated Drugs

8.0

Anomaly Score

Patient Profile

70

Avg Age

66%

Female

1.90

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data